ResMed Director Awarded RSU Grant for 1,073 Shares
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ResMed Director Awarded RSU Grant for 1,073 Shares
Company: RESMED INC (RMD) Form: 4 | Filed: 2025/11/24 Significance: Low
Insider: Gill Harjit Title: Director | Relationship: Director
Transaction: • Type: Grant • Shares: 1,073 • Price: $0.00 • Value: $0 • Owned After: 10,940
Key Insight: This is a routine grant of Restricted Stock Units (RSUs) to a director as part of their compensation, with a negligible impact on total shares outstanding.
Market Context: For a large-cap company like ResMed ($35.68B market cap), such grants are standard procedure and do not typically signal new market-moving information.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: RESMED INC (RMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director was awarded a routine grant of 1,073 Restricted Stock Units (RSUs) as part of a standard compensation plan.
- Market Impact: Neutral. This transaction is a non-market event and is not expected to influence trading activity.
Company Information
| Field | Value |
|---|---|
| Company | RESMED INC |
| Ticker Symbol | RMD |
| CIK | 0000943819 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Gill Harjit |
| CIK | 0001759311 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-20 |
| Transaction Code | A (Award) |
| Security Type | ResMed Common Stock |
| Shares Involved | 1,073 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 10,940 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 1,073 |
| % of Shares Outstanding | 0.0007% |
| Post-Transaction Ownership | 10,940 shares (0.007% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction involves $0 value against a market capitalization of $35.68 billion, making it financially immaterial.
- Ownership Concentration: The director's post-transaction ownership remains very small at 0.007% of total shares outstanding.
- Dilution Impact: The grant of 1,073 shares represents a negligible 0.0007% of shares outstanding, resulting in minimal dilution for existing shareholders.
- Transaction Significance: The transaction is a routine RSU grant, a common form of non-cash compensation for directors, and holds no significance as a market signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market transaction (an award, not a purchase) and is a standard part of executive/director compensation. It does not reflect insider sentiment based on market conditions.
Volume & Sentiment
- Expected Volume Impact: None. The transaction did not occur on the open market.
- Sentiment Indicator: Neutral. The filing is informational and relates to compensation, not a strategic investment decision by the insider.
Additional Context
Transaction Notes
- Special Circumstances: The filing footnote specifies these are Restricted Stock Units (RSUs) that vest in full on the earlier of November 11, 2026, or the annual stockholders' meeting in the year following the grant. This means the insider does not yet own the shares outright.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.